Product Comparison
No Image |
|||||
---|---|---|---|---|---|
McKesson # | 649570 | 802921 | 1031141 | 558503 | 467253 |
Description | Butorphanol Tartrate 2 mg / mL Injection Vial 1 mL CIV | Buprenorphine HCl 2 mg Tablet Bottle 30 Tablets CIII | Buprenorphine HCl 8 mg Tablet Bottle 30 Tablets CIII | Butorphanol Tartrate 1 mg / mL Injection Vial 1 mL CIV | Nalbuphine HCl 20 mg / mL Injection Multiple-Dose Vial 10 mL CIV |
Manufacturer # | 00409162601 | 50383092493 | 50383093093 | 00409162301 | 00409146701 |
Brand | |||||
Manufacturer | Hospira | Akorn | Akorn | Hospira | Hospira |
Invoice | BUTORPHANOL, VL 2MG/ML 1ML (10/CT) CIV | BUPRENORPHINE, TAB 2MG (30/BT)CIII 9HITEC | BUPRENORPHINE, TAB SUBL 8MG (30EA/BT) CIII D/S | BUTORPHAN, VL 1MG/ML 1ML (10/BX) CIV | NALBUPHINE, VL 20MG/ML 10ML (25/CT) CIV |
Log In to Order | Log In to Order | Log In to Order | Log In to Order | Log In to Order | |
Comparison |
|||||
Alternate Manufacturer Number | 1775147 | 1298728 | 1299965 | 1770619 | 1765205 |
Alternate Packaging | CT/25 | ||||
Container Type | Vial | Bottle | Bottle | Vial | Multiple-Dose Vial |
Dosage Form | Injection | Tablet | Tablet | Injection | Injection |
Drug Schedule | CIV | CIII | CIII | CIV | CIV |
Generic Drug Code | 16551 | 64672 | 64673 | 16550 | 16371 |
Generic Drug Name | Butorphanol Tartrate | Buprenorphine HCl | Buprenorphine HCl | Butorphanol Tartrate | Nalbuphine HCl |
NDC Number | 00409162601 | 50383092493 | 50383093093 | 00409162301 | 00409146701 |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | ||
Quantity | 30 Tablets | 30 Tablets | |||
Strength | 2 mg / mL | 2 mg | 8 mg | 1 mg / mL | 20 mg / mL |
Type | Sublingual | Sublingual | Intramuscular, Intravenous, or Subcutaneous | ||
UNSPSC Code | 51372023 | 51372003 | 51372022 | 51372023 | 51372016 |
Volume | 1 mL | 1 mL | 10 mL | ||
Application | Opiate Partial Agonist | Opiate Partial Agonist | Opiate Partial Agonist | Opiate Partial Agonist | Opiate Partial Agonist |
Country of Origin | Unknown | Unknown | Unknown | Unknown | Unknown |
Features and Benefits |
|
|
|
|
|